000 | 01182 a2200337 4500 | ||
---|---|---|---|
005 | 20250512064026.0 | ||
264 | 0 | _c19871116 | |
008 | 198711s 0 0 eng d | ||
022 | _a0361-7742 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDroz, J P | |
245 | 0 | 0 |
_aPhase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate. _h[electronic resource] |
260 |
_bProgress in clinical and biological research _c1987 |
||
300 |
_a235-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
700 | 1 | _aFargeot, P | |
700 | 1 | _aLaplaige, P | |
700 | 1 | _aMoran-Ribon, A | |
700 | 1 | _aPiot, G | |
773 | 0 |
_tProgress in clinical and biological research _gvol. 243B _gp. 235-42 |
|
999 |
_c3664724 _d3664724 |